MicroRNAs as potential biomarkers for monitoring of acquired sensorineural hearing loss

Abstract

Presbyacusis, sudden sensorineural hearing loss (SNHL), noise-induced hearing loss, and drug-induced deafness are the most common types of acquired SNHL. At present, the diagnosis of these hearing disorders is mainly based on the medical history and audiological examination. Due to the lack of diagnostic biomarkers, diagnosis of acquired sensorineural hearing loss is difficult. Previous studies have suggested that microRNAs (miRNAs) serve essential roles in pathophysiological processes, and they are stable, tissue enriched, and could be determined in a quantitative manner. Therefore, they could be potential noninvasive biomarkers for acquired SNHL. This review provided a comprehensive overview of the similarities and differences in altered circulating miRNAs (cimiRNAs) (plasma, serum, whole blood, and perilymph) in various disorders, and highlighted the regulatory functions of cimiRNAs on the development, monitoring and prognosis of the four most common types of acquired SNHL.

Keywords

biomarkers / circulating miRNAs / deafness / sensorineural hearing loss

References

[1] Thylefors BI. The WHO programme for the prevention of deafness and hearing impairment. Scand Audiol Suppl. 1996;42:21-22.

[2] World Health Organization. World Report on Hearing. World Health Organization; March 2021. Accessed August 2023. https://who.int/publications/i/item/9789240020481

[3] Cunningham LL, Tucci DL. Hearing loss in adults. N Engl J Med. 2017;377(25):2465-2473.

[4] Walling AD, Dickson GM. Hearing loss in older adults. Am Fam Physician. 2012;85:1150-1156.

[5] Wu X, Zou SY, Wu F, He Z, Kong W. Role of microRNA in inner ear stem cells and related research progress. Am J Stem Cells. 2020;9:16-24.

[6] Roland L, Fischer C, Tran K, Rachakonda T, Kallogjeri D, Lieu JE. Quality of life in children with hearing impairment: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016;155(2):208-219.

[7] Tseng CC, Hu LY, Liu ME, Yang AC, Shen CC, Tsai SJ. Risk of depressive disorders following sudden sensorineural hearing loss: a nationwide population-based retrospective cohort study. J Affect Disord. 2016;197:94-99.

[8] Chen HHR, Wijesinghe P, Nunez DA. MicroRNAs in acquired sensorineural hearing loss. J Laryngol Otol. 2019;133(8):650-657.

[9] Miao L, Wang BS, Zhang J, Yin LH, Pu YP. A functional SNP in miR-625-5p binding site of AKT2 3'UTR is associated with noise-induced hearing loss susceptibility in the Chinese population. Environ Sci Pollut Res Int. 2021;28(30):40782-40792.

[10] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.

[11] Mohammed J, Flynt AS, Siepel A, Lai EC. The impact of age, biogenesis, and genomic clustering on Drosophila microRNA evolution. RNA. 2013;19(9):1295-1308.

[12] Wang X, Ning YJ, Yang L, et al. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis. Clin Exp Med. 2017;17(2):175-183.

[13] Wojciechowska A, Braniewska A, Kozar-Kamińska K. MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med. 2017;26(5):865-874.

[14] Grasso M, Piscopo P, Confaloni A, Denti MA. Circulating miRNAs as biomarkers for neurodegenerative disorders. Molecules. 2014;19(5):6891-6910.

[15] Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(Database):D152-D157.

[16] Mahmoudian-Sani MR, Mehri-Ghahfarrokhi A, Ahmadinejad F, Hashemzadeh-Chaleshtori M, Saidijam M, Jami MS. MicroRNAs: effective elements in ear-related diseases and hearing loss. Eur Arch Otorhinolaryngol. 2017;274(6):2373-2380.

[17] Soares E, Reis J, Rodrigues M, Ribeiro CF, Pereira FC. Circulating extracellular vesicles: the missing link between physical exercise and depression management?Int J Mol Sci. 2021;22(2):542.

[18] Glinge C, Clauss S, Boddum K, et al. Stability of circulating blood-based microRNAs - pre-analytic methodological considerations. PLoS One. 2017;12(2):e0167969.

[19] Szelenberger R, Kacprzak M, Saluk-Bijak J, Zielinska M, Bijak M. Plasma microRNA as a novel diagnostic. Clin Chim Acta. 2019;499:98-107.

[20] Wang J, Chen J, Sen SY, et al. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231(1):25-30.

[21] Matsuyama H, Suzuki HI. Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis. Int J Mol Sci. 2019;21(1):132.

[22] Forouzanfar F, Shojapour M, Asgharzade S, Amini E. Causes and consequences of microRNA dysregulation following cerebral ischemia-reperfusion injury. CNS Neurol Disord Drug Targets. 2019;18(3):212-221.

[23] Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451-5465.

[24] Zhelankin AV, Stonogina DA, Vasiliev SV, et al. Circulating extracellular miRNA analysis in patients with stable CAD and acute coronary syndromes. Biomolecules. 2021;11(7):962.

[25] Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?Circ Res. 2012;110(3):483-495.

[26] Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30):10513-10518.

[27] Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223-7233.

[28] Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13-21.

[29] Ionescu RF, Cretoiu SM. MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy. J Med Life. 2021;14(2):142-147.

[30] Shi D, Han M, Liu W, Tao J, Chen L. Circulating microRNAs as diagnostic biomarkers of clinical cognitive impairment: a meta-analysis. Am J Alzheimers Dis Other Demen. 2020;35:1533317520951686.

[31] Roy B, Yoshino Y, Allen L, Prall K, Schell G, Dwivedi Y. Exploiting circulating microRNAs as biomarkers in psychiatric disorders. Mol Diagn Ther. 2020;24(3):279-298.

[32] Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science. 2005;309(5732):310-311.

[33] Sekine K, Matsumura T, Takizawa T, et al. Expression profiling of microRNAs in the inner ear of elderly people by real-time PCR quantification. Audiol Neurootol. 2017;22(3):135-145.

[34] Zhang Q, Liu H, McGee J, Walsh EJ, Soukup GA, He DZ. Identifying microRNAs involved in degeneration of the organ of corti during age-related hearing loss. PLoS One. 2013;8(4):e62786.

[35] Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010;17(2):193-199.

[36] Sacheli R, Nguyen L, Borgs L, et al. Expression patterns of miR-96, miR-182 and miR-183 in the development inner ear. Gene Expr Patterns. 2009;9(5):364-370.

[37] Chadly DM, Best J, Ran C, et al. Developmental profiling of microRNAs in the human embryonic inner ear. PLoS One. 2018;13(1):e0191452.

[38] Kuhn S, Johnson SL, Furness DN, et al. miR-96 regulates the progression of differentiation in mammalian cochlear inner and outer hair cells. Proc Natl Acad Sci USA. 2011;108(6):2355-2360.

[39] Lewis MA, Di Domenico F, Ingham NJ, Prosser HM, Stell PK. Hearing impairment due to Mir183/96/182 mutations suggests both loss and gain of function effects. Dis Model Mech. 2020;14(2):dmm047225.

[40] Shew M, Warnecke A, Lenarz T, Schmitt H, Gunewardena S, Staecker H. Feasibility of microRNA profiling in human inner ear perilymph. Neuroreport. 2018;29(11):894-901.

[41] Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B. The pervasive role of the miR-181 family in development, neurodegeneration, and cancer. Int J Mol Sci. 2020;21(6):2092.

[42] Henao-Mejia J, Williams A, Goff LA, et al. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity. 2013;38(5):984-997.

[43] Indrieri A, Carrella S, Romano A, et al. miR-181a/b downregulation exerts a protective action on mitochondrial disease models. EMBO Mol Med. 2019;11(5):e8734.

[44] Carrella S, Barbato S, D'Agostino Y, et al. TGF-beta controls miR-181/ERK regulatory network during retinal axon specification and growth. PLoS One. 2015;10(12):e0144129.

[45] Takousis P, Sadlon A, Schulz J, et al. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid. Alzheimers Dement. 2019;15(11):1468-1477.

[46] Liu N, Landreh M, Cao K, et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature. 2012;482(7386):519-523.

[47] Li N, Bates DJ, An J, Terry DA, Wang E. Up-regulation of key microRNAs, and inverse down-regulation of their predicted oxidative phosphorylation target genes, during aging in mouse brain. Neurobiol Aging. 2011;32(5):944-955.

[48] Yang JE, Chen DP, He YN, et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age (Dordr). 2013;35(1):11-22.

[49] Xiong H, Pang JQ, Yang HD, et al. Activation of miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell apoptosis: implications for age-related hearing loss. Neurobiol Aging. 2015;36(4):1692-1701.

[50] Xiong H, Chen SJ, Lai L, et al. Modulation of miR-34a/SIRT1 signaling protects cochlear hair cells against oxidative stress and delays age-related hearing loss through coordinated regulation of mitophagy and mitochondrial biogenesis. Neurobiol Aging. 2019;79:30-42.

[51] Huang Q, Zheng Y, Ou Y, et al. miR-34a/Bcl-2 signaling pathway contributes to age-related hearing loss by modulating hair cell apoptosis. Neurosci Lett. 2017;661:51-56.

[52] Pang JQ, Xiong H, Yang HD, et al. Circulating miR-34a levels correlate with age-related hearing loss in mice and humans. Exp Gerontol. 2016;76:58-67.

[53] Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1-S45.

[54] Doo JG, Kim D, Kim Y, et al. Biomarkers suggesting favorable prognostic outcomes in sudden sensorineural hearing loss. Int J Mol Sci. 2020;21(19):7248.

[55] Li Q, Peng X, Huang H, Li J, Wang F, Wang J. RNA sequencing uncovers the key microRNAs potentially contributing to sudden sensorineural hearing loss. Medicine (Baltimore). 2017;96(47):e8837.

[56] Nunez DA, Wijesinghe P, Nabi S, Yeh D, Garnis C. MicroRNAs in sudden hearing loss. Laryngoscope. 2020;130(6):E416-E422.

[57] Ha SM, Hwang KR, Park IH, et al. Circulating microRNAs as potentially new diagnostic biomarkers of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2020;140(12):1013-1020.

[58] Mittal R, Liu G, Polineni SP, Bencie N, Yan D, Liu XZ. Role of microRNAs in inner ear development and hearing loss. Gene. 2019;686:49-55.

[59] Hui X, Al-Ward H, Shaher F, Liu CY, Liu N. The role of miR-210 in the biological system: a current overview. Hum Hered. 2019;84(6):233-239.

[60] Riccardi S, Bergling S, Sigoillot F, et al. MiR-210 promotes sensory hair cell formation in the organ of corti. BMC Genomics. 2016;17:309.

[61] Kurkewich JL, Hansen J, Klopfenstein N, et al. The miR-23a∼27a∼24-2 microRNA cluster buffers transcription and signaling pathways during hematopoiesis. PLoS Genet. 2017;13(7):e1006887.

[62] Dar AA, Majid S, Rittsteuer C, et al. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst. 2013;105(6):433-442.

[63] Laos M, Sulg M, Herranen A, Anttonen T, Pirvola U. Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development. Sci Rep. 2017;7:42216.

[64] Lavinsky J, Ge M, Crow AL, et al. The genetic architecture of noise-induced hearing loss: evidence for a gene-by-environment interaction. G3 (Bethesda). 2016;6(10):3219-3228.

[65] Davis RR, Kozel P, Erway LC. Genetic influences in individual susceptibility to noise: a review. Noise Health. 2003;5(20):19-28.

[66] Ding E, Wang H, Han L, Zhang H, Zhu B. Variations in the potassium voltage-gated channel subfamily E regulatory subunit 1 gene associated with noise-induced hearing loss in the Chinese population. Environ Sci Pollut Res Int. 2020;27(15):18822-18830.

[67] Niu YG, Xie CY, Du ZH, et al. Genome-wide association study identifies 7q11.22 and 7q36.3 associated with noise-induced hearing loss among Chinese population. J Cell Mol Med. 2021;25(1):411-420.

[68] Sliwinska-Kowalska M, Pawelczyk M. Contribution of genetic factors to noise-induced hearing loss: a human studies review. Mutat Res. 2013;752(1):61-65.

[69] Miguel V, Cui JY, Daimiel L, et al. The role of microRNAs in environmental risk factors, noise-induced hearing loss and mental stress. Antioxid Redox Signal. 2018;28(9):773-796.

[70] Forouzanfar F, Asgharzade S. MicroRNAs in noise-induced hearing loss and their regulation by oxidative stress and inflammation. Curr Drug Targets. 2020;21(12):1216-1224.

[71] Ding L, Liu J, Shen HX, et al. Analysis of plasma microRNA expression profiles in male textile workers with noise-induced hearing loss. Hear Res. 2016;333:275-282.

[72] Li YH, Yang Y, Yan YT, et al. Analysis of serum microRNA expression in male workers with occupational noise-induced hearing loss. Braz J Med Biol Res. 2018;51(3):e6426.

[73] Zhang D, Lee H, Cao Y, Dela Cruz CS, Jin Y. miR-185 mediates lung epithelial cell death after oxidative stress. Am J Physiol Lung Cell Mol Physiol. 2016;310(7):L700-L710.

[74] Qu FJ, Cui XG, Hong Y, et al. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem. 2013;377(1-2):121-130.

[75] Khordadmehr M, Jigari-Asl F, Ezzati H, et al. A comprehensive review on miR-451: a promising cancer biomarker with therapeutic potential. J Cell Physiol. 2019;234(12):21716-21731.

[76] Zhang XW, Wang XH, Zhu HY, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster inprotection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol. 2010;49(5):841-850.

[77] Wang XH, Zhu HY, Zhang XW, et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res. 2012;94(2):379-390.

[78] Wang Z, Liu YM, Han N, et al. Profiles of oxidative stress-related microRNA and mRNA expression in auditory cells. Brain Res. 2010;1346:14-25.

[79] Kurioka T, Matsunobu T, Satoh Y, et al. ERK2 mediates inner hair cell survival and decreases susceptibility to noise-induced hearing loss. Sci Rep. 2015;5:16839.

[80] Cianfrone G, Pentangelo D, Cianfrone F, et al. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide. Eur Rev Med Pharmacol Sci. 2011;15(6):601-636.

[81] Li HW, Chai RJ. Hearing Loss: Mechanisms, Prevention and Cure: Advances in Experimental Medicine and Biology 1130. Springer; 2019.

[82] Lee SH, Ju HM, Choi JS, Ahn Y, Lee S, Seo YJ. Circulating serum miRNA-205 as a diagnostic biomarker for ototoxicity in mice treated with aminoglycoside antibiotics. Int J Mol Sci. 2018;19(9):2836.

[83] Ryan DG, Oliveira-Fernandes M, Lavker RM, et al. MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis. 2006;12:1175-1184.

[84] Muratsu-Ikeda S, Nangaku M, Ikeda Y, Tanaka T, Wada T, Inagi R. Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. PLoS One. 2012;7(7):e41462.

[85] Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist. 2010;15(7):673-682.

[86] Wang HJ, Cai J. The role of microRNAs in heart failure. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):2019-2030.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children's Hospital of Chongqing Medical University.